KORDASTI, Shahram Yaser
 Distribuzione geografica
Continente #
NA - Nord America 2.879
AS - Asia 1.467
EU - Europa 1.062
SA - Sud America 367
AF - Africa 101
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 5.881
Nazione #
US - Stati Uniti d'America 2.818
SG - Singapore 460
RU - Federazione Russa 332
VN - Vietnam 299
BR - Brasile 295
CN - Cina 251
HK - Hong Kong 238
IT - Italia 187
FR - Francia 109
IE - Irlanda 109
SE - Svezia 88
GB - Regno Unito 63
IN - India 56
DE - Germania 42
CI - Costa d'Avorio 36
CA - Canada 29
AR - Argentina 25
FI - Finlandia 24
PL - Polonia 23
BD - Bangladesh 22
MX - Messico 22
AT - Austria 20
NL - Olanda 20
ZA - Sudafrica 19
IQ - Iraq 16
TR - Turchia 15
ID - Indonesia 13
JP - Giappone 13
EC - Ecuador 12
ES - Italia 12
MA - Marocco 12
PY - Paraguay 10
VE - Venezuela 10
PH - Filippine 9
PK - Pakistan 9
CO - Colombia 7
SA - Arabia Saudita 7
TH - Thailandia 7
DZ - Algeria 6
KE - Kenya 6
UA - Ucraina 6
UZ - Uzbekistan 6
EG - Egitto 5
JO - Giordania 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
JM - Giamaica 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
CL - Cile 3
ET - Etiopia 3
EU - Europa 3
KR - Corea 3
PS - Palestinian Territory 3
PT - Portogallo 3
SN - Senegal 3
TW - Taiwan 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
IL - Israele 2
IR - Iran 2
KZ - Kazakistan 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BY - Bielorussia 1
CR - Costa Rica 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MR - Mauritania 1
NC - Nuova Caledonia 1
NG - Nigeria 1
PE - Perù 1
QA - Qatar 1
RO - Romania 1
SY - Repubblica araba siriana 1
SZ - Regno dello Swaziland 1
Totale 5.881
Città #
Ashburn 593
Des Moines 380
Chandler 310
Singapore 307
San Jose 267
Hong Kong 233
Dallas 112
Dublin 108
Boardman 99
Ho Chi Minh City 86
Hanoi 71
Fairfield 67
Beijing 65
The Dalles 64
Lauterbourg 60
Los Angeles 50
Moscow 44
New York 40
Hefei 39
Abidjan 36
Ancona 35
Lawrence 30
Princeton 30
San Mateo 28
Wilmington 28
Council Bluffs 25
Pune 25
Orem 23
Buffalo 22
São Paulo 22
Helsinki 21
Houston 21
Seattle 21
Woodbridge 21
Warsaw 20
Nuremberg 19
Turin 19
Falls Church 18
Milan 17
Cambridge 16
Marche 16
Chicago 15
Rio de Janeiro 15
Rome 15
Da Nang 14
Ann Arbor 13
Montreal 13
Frankfurt am Main 12
Phoenix 12
Tokyo 12
Vienna 12
Haiphong 11
San Diego 11
Santa Clara 11
Stockholm 11
Columbus 10
Denver 10
Washington 10
San Francisco 9
Shanghai 9
Amsterdam 8
Boston 8
Brasília 8
Chennai 8
Manchester 8
Ankara 7
Brooklyn 7
Johannesburg 7
London 7
Norwalk 7
Bangkok 6
Dong Ket 6
Falconara Marittima 6
Guayaquil 6
Istanbul 6
Mexico City 6
Tashkent 6
Amman 5
Atlanta 5
Baghdad 5
Campinas 5
Goiânia 5
Guangzhou 5
Hải Dương 5
Medellín 5
Portsmouth 5
Southwark 5
Asunción 4
Belo Horizonte 4
Bologna 4
Bến Tre 4
Cape Town 4
Dhaka 4
Elk Grove Village 4
Guarulhos 4
Jakarta 4
Karbala 4
Montesilvano Marina 4
Munich 4
Nairobi 4
Totale 3.952
Nome #
Deep phenotyping of tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment 175
Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells 159
Human retinoic acid–regulated CD161 + regulatory T cells support wound repair in intestinal mucosa 134
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation 132
Anti-TNF treatment negatively regulates human CD4+ T-cell activation and maturation in vitro, but does not confer an anergic or suppressive phenotype 127
Targeting the immune system in MDS and MPN: Understanding the immunome and response to immunotherapy - Part 2 122
Thrombomodulin-expressing monocytes are associated with low-risk features in myelodysplastic syndromes and dampen excessive immune activation 121
Uncommon Presentation of Sarcoidosis with Severe Thrombocytopenia and Hemorrhagic Diathesis 120
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues. Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group 120
Treg sensitivity to FasL and relative IL-2 deprivation drive idiopathic aplastic anemia immune dysfunction 117
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes 117
Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression 112
COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients 110
Reduced frequencies and functional impairment of dendritic cell subsets and non-classical monocytes in myelodysplastic syndromes 110
Immunocluster provides a computational framework for the nonspecialist to profile high-dimensional cytometry data 110
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre 110
Integrating the “Immunome” in the stratification of myelodysplastic syndromes and future clinical trial design 108
A Crohn's disease-associated IL2RA enhancer variant determines the balance of T cell immunity by regulating responsiveness to IL-2 signaling 108
Pitfalls in the characterization of circulating and tissue-resident human γδ T cells 107
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 104
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study 103
Transcriptional profiling reveals functional dichotomy between human slan+ non-classical monocytes and myeloid dendritic cells 101
SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation 99
Cluster stability in the analysis of mass cytometry data 98
Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London 97
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 95
Deep phenotyping detects a pathological CD4+ T-cell complosome signature in systemic sclerosis 94
Human bone marrow-derived myeloid dendritic cells show an immature transcriptional and functional profile compared to their peripheral blood counterparts and separate from slan+ non-classical monocytes 94
Altered immune response to the annual influenza A vaccine in patients with myeloproliferative neoplasms 92
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype 89
Essential thrombocythaemia treated with recombinant interferon: ‘real world' United Kingdom referral centre experience 87
Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer 87
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms 85
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes 84
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran 83
Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 82
Patients with triple-negative, JAK2V617F- A nd CALR-mutated essential thrombocythemia share a unique gene expression signature 82
Vitamin B5 and succinyl-CoA improve ineffective erythropoiesis in SF3B1-mutated myelodysplasia 81
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients 80
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes 79
Natural born survivors: The inglorious TP53 77
Immune-monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium 72
Predicting progression-free survival after systemic therapy in advanced head and neck cancer: Bayesian regression and model development 69
Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation 68
JAK inhibition induces silencing of T Helper cytokine secretion and a profound reduction in T regulatory cells 68
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib 66
LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer 65
Human autoimmunity at single cell resolution in aplastic anemia before and after effective immunotherapy 64
Baseline cytokine profiling identifies novel risk factors for invasive fungal disease among haematology patients undergoing intensive chemotherapy or haematopoietic stem cell transplantation 62
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 61
Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party 61
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS) 60
Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome 60
Chronic relapsing remitting Sweet syndrome - a harbinger of myelodysplastic syndrome 59
Marginal Zone Lymphoma Manifesting as Macrophage Activation Syndrome: A Case Report 57
Hostile Takeover: Tregs Expand in IFNγ-Rich AML Microenvironment 57
Regulatory T cell niche in the bone marrow, a new player in Haematopoietic stem cell transplantation 57
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group 56
CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner 56
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group 55
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab 53
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralisation in patients with chronic myeloid disorders 52
Human CD80/IL2 lentivirus-transduced acute myeloid leukaemia (AML) cells promote natural killer (NK) cell activation and cytolytic activity: Implications for a phase i clinical study 52
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms 51
Functional characterization of CD4+ T cells in aplastic anemia 49
IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome 49
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome 49
Dendritic cells in myelodysplastic syndromes: From pathogenesis to immunotherapy 48
Human CD80/IL2 lentivirus transduced acute myeloid leukaemia cells enhance cytolytic activity in vitro in spite of an increase in regulatory CD4 + T cells in a subset of cultures 47
The impact of COVID-19 in the cancer population stratified by age: A real-world data study from Guy's Cancer Center 47
Neoantigens in MDS Are Associated with Two Novel CD4+T Cell Subsets and Improved Overall Survival 45
Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: Implications for a possible immunomodulatory role 42
Totale 6.049
Categoria #
all - tutte 28.634
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 0 0 0 0 77 39
2021/2022331 2 79 0 1 12 32 7 9 33 20 52 84
2022/2023997 73 95 33 73 43 420 0 40 151 2 52 15
2023/2024460 71 26 32 40 66 74 14 14 0 49 17 57
2024/20251.241 75 117 46 18 47 73 202 64 254 74 111 160
2025/20262.904 170 169 174 207 322 236 654 328 345 299 0 0
Totale 6.049